Correlation Between Organogenesis Holdings and Shuttle Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Organogenesis Holdings and Shuttle Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Organogenesis Holdings and Shuttle Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Organogenesis Holdings and Shuttle Pharmaceuticals, you can compare the effects of market volatilities on Organogenesis Holdings and Shuttle Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Organogenesis Holdings with a short position of Shuttle Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Organogenesis Holdings and Shuttle Pharmaceuticals.
Diversification Opportunities for Organogenesis Holdings and Shuttle Pharmaceuticals
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Organogenesis and Shuttle is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Organogenesis Holdings and Shuttle Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shuttle Pharmaceuticals and Organogenesis Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Organogenesis Holdings are associated (or correlated) with Shuttle Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shuttle Pharmaceuticals has no effect on the direction of Organogenesis Holdings i.e., Organogenesis Holdings and Shuttle Pharmaceuticals go up and down completely randomly.
Pair Corralation between Organogenesis Holdings and Shuttle Pharmaceuticals
Given the investment horizon of 90 days Organogenesis Holdings is expected to generate 0.85 times more return on investment than Shuttle Pharmaceuticals. However, Organogenesis Holdings is 1.18 times less risky than Shuttle Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Shuttle Pharmaceuticals is currently generating about -0.07 per unit of risk. If you would invest 260.00 in Organogenesis Holdings on August 27, 2024 and sell it today you would earn a total of 145.00 from holding Organogenesis Holdings or generate 55.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Organogenesis Holdings vs. Shuttle Pharmaceuticals
Performance |
| Timeline |
| Organogenesis Holdings |
| Shuttle Pharmaceuticals |
Organogenesis Holdings and Shuttle Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Organogenesis Holdings and Shuttle Pharmaceuticals
The main advantage of trading using opposite Organogenesis Holdings and Shuttle Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Organogenesis Holdings position performs unexpectedly, Shuttle Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shuttle Pharmaceuticals will offset losses from the drop in Shuttle Pharmaceuticals' long position.| Organogenesis Holdings vs. Shuttle Pharmaceuticals | Organogenesis Holdings vs. Lifecore Biomedical | Organogenesis Holdings vs. Redhill Biopharma | Organogenesis Holdings vs. Collegium Pharmaceutical |
| Shuttle Pharmaceuticals vs. Lifecore Biomedical | Shuttle Pharmaceuticals vs. Catalent | Shuttle Pharmaceuticals vs. Tilray Inc | Shuttle Pharmaceuticals vs. Organogenesis Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |